iSpecimen
ISPC
13 hedge funds and large institutions have $813K invested in iSpecimen in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
8% more funds holding
Funds holding: 12 → 13 (+1)
0% more ownership
Funds ownership: 0% → 0.01% (+0%)
59% less capital invested
Capital invested by funds: $1.98M → $813K (-$1.17M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
Grimes & Company
Westborough,
Massachusetts
|
+$85.7K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$78.3K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$61.2K |
| 4 |
MSFS
Main Street Financial Solutions
Newtown,
Pennsylvania
|
+$31.8K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.89K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$56K |
| 2 |
BlackRock
New York
|
-$44.1K |
| 3 |
Citigroup
New York
|
-$9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BL
1
Bleichroeder LP
New York
| $144K | – | – | – |
|
|
GC
2
Grimes & Company
Westborough,
Massachusetts
| $135K | +$85.7K | +35 | +81% |
|
|
3
Vanguard Group
Malvern,
Pennsylvania
| $134K | +$78.3K | +32 | +71% |
|
|
4
BlackRock
New York
| $124K | -$44.1K | -18 | -20% |
|
|
TA
5
Teton Advisors
Rye,
New York
| $87K | – | – | – |
|
|
6
Geode Capital Management
Boston,
Massachusetts
| $50K | +$4.89K | +2 | +7% |
|
|
SSA
7
Schonfeld Strategic Advisors
New York
| $44K | – | – | – |
|
|
8
Citadel Advisors
Miami,
Florida
| $43K | +$61.2K | +25 | New |
|
|
MSFS
9
Main Street Financial Solutions
Newtown,
Pennsylvania
| $23K | +$31.8K | +13 | New |
|
10
Morgan Stanley
New York
| $11K | – | – | – |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| $11K | +$4.89K | +2 | +50% |
|
12
UBS Group
Zurich,
Switzerland
| $5K | +$4.89K | +2 | +200% |
|
13
Bank of America
Charlotte,
North Carolina
| $2K | +$2.45K | +1 | New |
|
|
14
Jane Street
New York
| – | -$56K | -13 | Closed |
|
|
15
Citigroup
New York
| – | -$9K | -2 | Closed |
|
ISPC Hedge Fund Activity: Q2 2022 in Review
13 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in iSpecimen (ISPC) for Q2 2022, worth a combined $813K — down 59% from $1.98M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ISPC positions and 2 closed out — a net gain of 1 holder — while 5 added to existing stakes and 1 trimmed.
The largest buyer was Grimes & Company, adding an estimated $85.7K. The largest seller was Jane Street, exiting entirely with an estimated $56K sold.
- 13 institutional investors held iSpecimen (ISPC) as of Q2 2022, up from 12 in Q1 2022.
- Funds reported $813K of iSpecimen stock for Q2 2022, down 59% quarter-over-quarter.
- 3 funds opened new iSpecimen positions in Q2 2022 and 2 closed out, a net change of +1 holder.
- The largest iSpecimen buyer in Q2 2022 was Grimes & Company, an estimated $85.7K added.
- The largest iSpecimen seller in Q2 2022 was Jane Street, an estimated $56K sold.
Based on aggregated 13F filings for Q2 2022.